Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Net Margin (2016 - 2025)

Historic Net Margin for Lisata Therapeutics (LSTA) over the last 11 years, with Q2 2025 value amounting to 6655.71%.

  • Lisata Therapeutics' Net Margin changed N/A to 6655.71% in Q2 2025 from the same period last year, while for Sep 2025 it was 1704.86%, marking a year-over-year change of. This contributed to the annual value of 1998.5% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Lisata Therapeutics' Net Margin is 6655.71%.
  • Lisata Therapeutics' 5-year Net Margin high stood at 461.0% for Q4 2024, and its period low was 6655.71% during Q2 2025.